First Pharmaceutical announced that revenue for the first half of 2026 was 982 million yuan, a year-on-year decrease of 1.51%; net profit attributable to shareholders of listed companies was 26.1698 million yuan, an increase of 86.60% over the same period in 2025; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,311,900 yuan, a year-on-year decrease of 85.44%.

First Pharmaceutical announced that revenue for the first half of 2026 was 982 million yuan, a year-on-year decrease of 1.51%; net profit attributable to shareholders of listed companies was 26.1698 million yuan, an increase of 86.60% over the same period in 2025; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,311,900 yuan, a year-on-year decrease of 85.44%.